Our Focus

Bringing people and knowledge together for a healthier world

Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment.

banner_team at board

950 employees who are Medical Doctors and 900 employees who are PhDs

All with experience across a number of fields and a particular focus on oncology, cardiovascular, central nervous system and internal medicine.

We work with biopharmaceutical and other life science companies with services and solutions that improve your probability of success, connecting insights with superior delivery for better outcomes. Quintiles' success begins and ends with your success. We share your goals and collaborate with you, bringing an industry recognized depth of expertise and breadth of perspective to shape better ideas. Our award-winning people, processes and technology drive predictable and efficient delivery around the globe. With more than 32,000 employees working in about 100 countries, we have helped develop or commercialize all of the top-100, best-selling drugs on the market in 2013. And it’s all done with an unwavering dedication to ethics and high quality, in the pursuit of success in human measures.

From pipeline through portfolio to population health

Profound shifts in healthcare are driving transformation. Advances in science, analytics and therapeutic knowledge offer the promise of better treatments. The healthcare industry has tremendous opportunity to conquer the global burden of disease, working together differently across the healthcare system with a focus on integration, evidence and value. Quintiles has a unique vantage point on this transformation and brings a fully integrated approach to build biopharma and life sciences solutions.

Product Development

Our Product Development group enables biopharmaceutical R&D and medical device companies, government and non-government organizations, and generic and biosimilar customers outsource clinical development, from first-in-human studies to post-launch monitoring. Our comprehensive services provide the expertise and capabilities as well as the systems and analytical expertise necessary at each stage of development. Clinical solutions and services include project management and clinical monitoring functions for conducting multi-site trials (generally Phase II-IV), collectively known as “core clinical.” Our global laboratories, data management, biostatistics, safety and pharmacovigilance, early clinical development (generally Phase I), and strategic planning and design services enable us to provide end-to-end solutions to our customers. Consulting provides strategy and management consulting services based on life science expertise and advanced analytics, as well as regulatory and compliance consulting services.

Integrated Healthcare Services

Our Integrated Healthcare Services (IHS) address the outsourced commercial needs of biopharmaceutical customers as well as the needs of the broader healthcare sector for value-based analyses, research studies and evidence-based medicine. Service offerings include commercial services such as sales representatives, strategy, market access, marketing communications and other areas related to commercialization. Outcomes research including drug therapy analysis, real-world research and evidence-based medicine, including research studies to prove a drug’s value are also part of our IHS offering along with comparative and cost-effectiveness research, clinical management analytics, decision support services, medication adherence and health outcome optimization services, and web-based systems for measuring quality improvement.

Video Spotlights
Together We Make Possible Probable
Together We Make Possible Probable